Kirtisinh Manoharsinh Parmar

This profile gathers the share dealings of Kirtisinh Manoharsinh Parmar in Corona Remedies. We count 7 filings, every one of them for a trade on 19 August 2026.

Purchases make up the whole of the open-market record (7 purchases, €3,486). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

A typical purchase (the median) is worth €661. Measured against the company's value, the median purchase equals 0.0001% of market capitalisation, across 7 purchases where it is known. Of 7 purchases, 7 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 19 August 2026, reports an open-market purchase of €112 in Corona Remedies. Publication is fast: at least half of the trades appear on SEBI (PIT + SAST) on the same day. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.